<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9215429</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2408</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Mutat</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mutat.</journal-id>
<journal-title-group>
<journal-title>Human mutation</journal-title>
</journal-title-group>
<issn pub-type="ppub">1059-7794</issn>
<issn pub-type="epub">1098-1004</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31297895</article-id>
<article-id pub-id-type="pmc">6744296</article-id>
<article-id pub-id-type="doi">10.1002/humu.23866</article-id>
<article-id pub-id-type="manuscript">NIHMS1041198</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Future directions for high-throughput splicing assays in precision medicine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rhine</surname>
<given-names>Christy L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neil</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glidden</surname>
<given-names>David T.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cygan</surname>
<given-names>Kamil J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fredericks</surname>
<given-names>Alger M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walton</surname>
<given-names>Nephi A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fairbrother</surname>
<given-names>William G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI.</aff>
<aff id="A2"><label>2</label>Center for Computational Molecular Biology, Brown University, Providence, RI.</aff>
<aff id="A3"><label>3</label>Hassenfeld Child Health Innovation Institute of Brown University, Providence, RI</aff>
<aff id="A4"><label>4</label>Genomic Medicine Institute, Geisinger, Danville, PA</aff>
<author-notes>
<fn fn-type="other" id="FN1">
<label>†</label>
<p id="P1">These authors contributed equally to this work</p>
</fn>
<corresp id="CR1"><label>*</label>Correspondence: <email>william_fairbrother@brown.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>4</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2020</year>
</pub-date>
<volume>40</volume>
<issue>9</issue>
<fpage>1225</fpage>
<lpage>1234</lpage>
<!--elocation-id from pubmed: 10.1002/humu.23866-->
<abstract id="ABS1">
<p id="P2">Classification of variants of unknown significance is a challenging technical problem in clinical genetics. As up to one third of disease-causing mutations are thought to affect pre-mRNA splicing, it is important to accurately classify splicing mutations in patient sequencing data. Several consortia and healthcare systems have conducted large-scale patient sequencing studies, which discover novel variants faster than they can be classified. Here we compare the advantages and limitations of several high-throughput splicing assays aimed at mitigating this bottleneck, and describe a dataset of ~5000 variants that we analyzed using our Massively Parallel Splicing Assay (MaPSy). The Critical Assessment of Genome Interpretation group (CAGI) organized a challenge, in which participants submitted machine learning models to predict the splicing effects of variants in this dataset. We discuss the winning submission of the challenge (MMSplice) which outperformed existing software. Finally, we highlight methods to overcome the limitations of MaPSy and similar assays, such as tissue-specific splicing, the effect of surrounding sequence context, classifying intronic variants, synthesizing large exons, and amplifying complex libraries of minigene species. Further development of these assays will greatly benefit the field of clinical genetics, which lack high-throughput methods for variant interpretation.</p>
</abstract>
<kwd-group>
<kwd>Splicing</kwd>
<kwd>precision medicine</kwd>
<kwd>disease</kwd>
<kwd>variant</kwd>
<kwd>assay</kwd>
<kwd>high-throughput</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>